Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/2010
01/21/2010US20100015204 Cell carrier and cell carrier containment devices containing regenerative cells
01/21/2010US20100015199 Method for suppressing generation of a teratoma
01/21/2010US20100015169 Tumor Antigens
01/21/2010US20100015153 Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same
01/21/2010US20100015150 Tdf-related compounds and analogs thereof
01/21/2010US20100015148 Methods and compositions for the utilization and targeting of osteomimicry
01/21/2010US20100015135 Anti-ephb4 antibodies and methods using same
01/21/2010US20100015133 Methods for Producing Polypeptides by Regulating Polypeptide Association
01/21/2010US20100015131 Composition Comprising Antibodies to LINGO or Fragments Thereof
01/21/2010US20100015120 Hybrid protein that converts arachidonic acid into prostacyclin
01/21/2010US20100015116 Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
01/21/2010US20100015112 Methods for the Induction of Professional and Cytokine-Producing Regulatory T Cells
01/21/2010US20100015108 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
01/21/2010US20100015107 Expression elements
01/21/2010US20100015106 Method and compositions for inhibiting tumorigenesis
01/21/2010US20100015104 Generation of adipose tissue and adipocytes
01/21/2010US20100015101 Novel tumor antigen peptides
01/21/2010US20100015100 Differentiation of human embryonic stem cells
01/21/2010US20100015099 Materials and methods relating to treatment of injury and disease to the central nervous system
01/21/2010US20100015093 Methods and compositions of treating a flaviviridae family viral infection
01/21/2010US20100015087 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
01/21/2010US20100015056 Uranium-chelating peptides and uses thereof
01/21/2010US20100015045 Cancerous Disease Modifying Antibodies
01/21/2010US20100011708 Coated polyamide film for bagging products with extended shelf life
01/21/2010DE102008033327A1 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik Silica material with at least one therapeutically active agent for the preparation of biologically degradable and / or resorbable silica gel materials for human medicine and / or medical
01/21/2010DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter
01/21/2010CA2734279A1 Glutamate decarboxylase (gad) transgenic plants that exhibit altered plant architecture
01/21/2010CA2734276A1 Glutamate decarboxylase (gad) transgenic plants with enhanced nitrogen uptake and utilisation
01/21/2010CA2731007A1 Method for production of reprogrammed cell using chromosomally unintegrated virus vector
01/21/2010CA2730928A1 Organ mimic device with microchannels and methods of use and manufacturing thereof
01/21/2010CA2730921A1 Recognition sequences for i-crei-derived meganucleases and uses thereof
01/21/2010CA2730668A1 New influenza virus immunizing epitope
01/21/2010CA2730661A1 Method for cell identification and cell sorting
01/21/2010CA2730546A1 Production of pluripotent cells through inhibition of bright/arid3a function
01/21/2010CA2730528A1 Methods and systems for manipulating particles using a fluidized bed
01/21/2010CA2730050A1 Composition comprising in vitro expanded t-lymphocytes and vessel formation inhibitors suitable in the treatment of cancer
01/21/2010CA2728477A1 Scalable process for culturing per.c6 cells and producing products therefrom
01/20/2010EP2145961A2 Porcine adenovirus type 3 genome
01/20/2010EP2145960A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with in-creased tolerance to environmental stress
01/20/2010EP2145958A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
01/20/2010EP2145954A1 Anti-A33 antibody
01/20/2010EP2145952A1 Method of degrading biological tissue
01/20/2010EP2144996A1 Carbon and nitrogen-regulating gene and protein and modulation thereof
01/20/2010EP2144639A2 New stem cell lines, their application and culture methods
01/20/2010EP1860184B1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide
01/20/2010EP1860183B1 Mutant glucose dehydrogenase
01/20/2010EP1771468B1 Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (trail)
01/20/2010EP1597380B1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells
01/20/2010EP1443970B1 Promoters exhibiting endothelial cell specificity and methods of using same
01/20/2010EP1379272B1 Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes
01/20/2010EP1363995B1 Use of a composition comprising n-acetylcysteine for conditioning stem cells
01/20/2010EP1355684B1 Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy
01/20/2010EP1257649B1 Corynebacterium glutamicum genes encoding metabolic pathway proteins
01/20/2010EP1188830B1 Novel hemopoietin receptor protein ,nr10
01/20/2010EP1117419B1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions
01/20/2010EP0971724B1 Expression of active human factor ix in mammary tissue of transgenic animals
01/20/2010EP0917538B1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
01/20/2010CN101631852A Methods and compositions for treatment of bone defects with placental cell populations
01/20/2010CN101631851A Novel regulatory T cells and uses thereof
01/20/2010CN101631850A Methods for increasing and mobilizing hematopoietic stem cells
01/20/2010CN101631559A Use of Semaphorin 6A for Promoting Myelination and Oligodendrocyte Differentiation
01/20/2010CN101629161A Aralia elate seem hormone autotrophic cell line
01/20/2010CN100582230C Expression of endogenous genes by non-homologons recombination of a vector construct with cellular DNA
01/20/2010CN100582224C Cellodextrin enzyme, encoding gene and application thereof
01/20/2010CN100582223C Transgenic rice culture method
01/20/2010CN100582221C Ultra low temperature freezing-storage method for onosma paniculatum cell
01/20/2010CN100581924C Airtight transporting blending metering method for powder culture medium
01/20/2010CN100581502C Human soft tissue filler for injection, and its preparation method
01/20/2010CN100581355C Sperm cell processing and preservation systems
01/20/2010CN100581353C Artificial rapid reproduction method for rutaceae zanthoxylum plant zanthoxylum dissitum Hemsl
01/20/2010CN100581352C Method for high frequency plant regenerating of tallow tree tissue culture adventitious bud
01/19/2010US7649129 Soybean variety 4305498
01/19/2010US7649128 Soybean variety D4521369
01/19/2010US7649127 Soybean cultivar 6135319
01/19/2010US7649088 Diagnosis and treatment of Hereditary Spastic Paraplegia
01/19/2010US7649085 Saquinavir conjugates and antibodies useful in immunoassay
01/19/2010US7649082 Glial-derived neurotrophic factor (GDNF)/neurturin family of growth factors; Neurodegenerative disorders; used in preventing the atrophy, degeneration or death of certain cells, in particular neurons
01/19/2010US7648964 In response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair; glycoprotein
01/19/2010US7648833 For forming embryoid bodies from embryonic stem (ES) cells easily and efficiently without complicated technique
01/19/2010US7648826 Detecting CYP24 expression level as a marker for predisposition to cancer
01/19/2010US7648699 Preventing transfusion related complications in a recipient of a blood transfusion
01/19/2010CA2301891C Rna respiratory synctial virus vaccines
01/19/2010CA2123492C Lymphoid antigen cd30
01/16/2010CA2671787A1 Methods for producing secreted proteins
01/14/2010WO2010006342A2 Compositions and methods for inhibiting expression of gsk-3 genes
01/14/2010WO2010006296A2 New avian bornavirus
01/14/2010WO2010006072A2 Mtor modulators and uses thereof
01/14/2010WO2010005995A1 Micropatterned co-culture systems as infectious disease analysis platforms
01/14/2010WO2010005863A1 Surface display of whole antibodies in eukaryotes
01/14/2010WO2010005527A1 Treatment of eye diseases and excessive neovascularization using a combined therapy
01/14/2010WO2010004989A1 Method for production of pluripotent stem cell
01/14/2010WO2010004204A2 Fgf-r4 receptor-specific antagonists
01/14/2010WO2010003540A2 A method for the formation of megamitochondria
01/14/2010WO2009143387A3 Modulation of smrt expression
01/14/2010WO2009142770A3 Compositions and methods for generating musculoskeletal tissue
01/14/2010WO2009142735A3 LUCIFERASE BIOSENSORS FOR cAMP
01/14/2010WO2009140754A8 An anti-cancer cytotoxic monoclonal antibody
01/14/2010WO2009137238A3 Irx-2 modified manufacturing process
01/14/2010WO2009137146A9 Method for producing continuous cell lines
01/14/2010WO2009134409A3 Neural regenerating cells with alterations in dna methylation